All articles by Hemanth Kumar

IDgenetix test shows increase in medication response and remission in study

Castle Biosciences’ IDgenetix pharmacogenomic test has showcased significant improvement in medication response and remission rates in patients with depressive disorder…
Revamp closes funding to support clinical programme for Doraya catheter

Israel-based company Revamp Medical has closed a Series A preferred stock financing to support clinical trials for its Doraya catheter…
QuantalX secures breakthrough device status for Delphi-MD

QuantalX has received breakthrough device designation from the US Food and Drug Administration (FDA) for its Delphi-MD neurodiagnostic device for…
Blue Earth Diagnostics receives FDA approval for Posluma injection

Blue Earth Diagnostics has received approval from the US Food and Drug Administration (FDA) for its Posluma (flotufolastat F 18)…
LG Electronics launches new diagnostic monitor with IPS Black panel

LG Electronics (LG) has launched a new 31.5in diagnostic monitor with an in-plane switching (IPS) Black panel. The product comes…

Guardant Health secures approval for liquid biopsy test in Singapore

Guardant Health has received approval from Singapore's Health Sciences Authority (HSA) for Guardant360 CDx, a liquid biopsy test for patients…
Sanofi study shows Dario solution reduces healthcare resource utilisation

In a recent research study conducted by Sanofi US (Sanofi, digital therapeutics company DarioHealth’s (Dario) digital health solution has demonstrated…
MaximBio receives contract from NIH to develop new rapid test platform

Diagnostic solutions manufacturer MaximBio has received a new contract from the National Institutes of Health (NIH) for the development of…
Thermo Fisher and Pfizer to enhance access to NGS testing for cancer

Thermo Fisher Scientific (Thermo Fisher) has signed a partnership agreement with Pfizer to increase localised access to next-generation sequencing (NGS)-based…
Sernova and AstraZeneca team to study novel therapeutic cell applications

Cell therapeutics company Sernova has signed a preclinical research collaboration agreement with AstraZeneca to assess the potential use of its…